Refractory Diffuse Large B-Cell Lymphoma: Clinical Trials

1 trial for Refractory Diffuse Large B-Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Refractory Diffuse Large B-Cell Lymphoma: new trials by email Literature Review of Refractory Diffuse Large B-Cell Lymphoma trials Research Report on Refractory Diffuse Large B-Cell Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
Carboplatin, Etoposide, Ifosfamide - Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma
Phase 1 / Phase 2UnknownAcademic and Community Cancer Research United302016-05-202024-07-01

Narrower conditions

Lymphoma, B-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

CT-P10 (1)  ·  Carboplatin (1)  ·  Etoposide (1)  ·  Ifosfamide (1)  ·  Lenalidomide (1)  ·  Rituximab (1)

Sponsors

Academic and Community Cancer Research United (1)

Countries

United States (1)

Top investigators

Grzegorz S Nowakowski (1)

NIH funding

P30CA015083 (1)